Stable with slight increase due to demand for pharmaceutical intermediates.
Special Rates
Preferential Rate
0%
Applicable under specific trade agreements or for pharmaceutical use with prior authorization from the Algerian Ministry of Health.
Additional Information
No additional information available.
Last updated: 1 year ago
News and Updates
Recent News
US Increases Export of Synthetic Alkaloids to Algeria
The United States reported a 20% increase in the export of synthetic alkaloids and their derivatives to Algeria in Q3 2023, driven by demand in the pharmaceutical sector.
2023-10-15
Impact: This surge strengthens trade ties and boosts US export revenue, potentially leading to more consistent supply agreements.
Algeria Implements Stricter Import Standards for Alkaloid Derivatives
Algeria introduced new quality control measures for imported alkaloids and derivatives, affecting US shipments under HS Code 2939, to ensure compliance with local pharmaceutical regulations.
2023-09-05
Impact: US exporters may face delays or increased costs to meet the new standards, potentially impacting trade volume temporarily.
During recent bilateral trade discussions, both nations emphasized the growing importance of alkaloids and their derivatives in trade, with a focus on sustainable supply chains for pharmaceutical applications.
2023-08-20
Impact: These talks could lead to long-term trade agreements, reducing tariffs and enhancing market access for US exporters.
Policy Updates
Algeria Updates Tariff Rates for HS Code 2939
Algeria revised tariff rates for alkaloids and their derivatives under HS Code 2939, increasing duties by 5% to support local production while maintaining import quality standards.
Date: 2023-09-10
US Extends Export Compliance Support for Alkaloid Trade
The US Department of Commerce announced new guidelines and support programs to help exporters of alkaloids and derivatives comply with international trade regulations, including those specific to Algeria.
